etectRx, Inc. Announces Issuance of U.S. Patent for Ingestible Medication Compliance System
GAINESVILLE, Fla. (Sept. 7, 2017) – etectRx™, Inc., an early stage digital health company, today announces that the United States Patent and Trademark Office has issued U.S. Patent 9,743,880 for an “Electronic Medication Compliance Monitoring System and Associated Methods.” The patent covers an ingestible electronic tag system and a method for monitoring a patient’s compliance
September 7, 2017